Homozygous or compound heterozygous mutations in the ATP13A2 gene lead to the development of the CLN12 (Kufor‐Rakeb syndrome) with juvenile onset. This evidence concerns the gene ATP13A2 and parkinsonism due to ATP13A2 deficiency.